Search

everythinglearnresearchcommunity

for

Search:↓

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Finasteride may cause floppy-iris syndrome during cataract surgery, so check patients' medical history.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

New treatments for male hypogonadism are effective and should be personalized.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

New drug shows promise for better hair growth in baldness treatment.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.